Neutralizing Antibodies to Interferon β-1b are not Associated with Disease Worsening in Multiple Sclerosis

By Goodin DS   Hurwitz B   Noronha A  

The Journal of International Medical Research, Vol. 35, Iss. 2, 2007-03 ,pp. : 173-187

Field House Publishing

Access to resources Recommend Favorite

Neutralizing antibodies to interferon β-1b are not associated with disease worsening in multiple sclerosis.

By Farrell Rachel   Bendtzen Klaus   Bertolotto Antonio   Clark Berwyn   Comabella Manuel   Deisenhammer Florian   Fogdell-Hahn Anna   Giovannoni Gavin   Hartung Hans Peter   Hemmer Bernard   Hillert Jan   Kappos Ludwig   Killestein Joep   Lindberg Raija   Montalban Xavier   Polman Chris   Sorensen Per Soelberg   Goodin DS   Hurwitz B   Noronha A  

The Journal of International Medical Research, Vol. 36, Iss. 1, 2008-01 ,pp. : 204-210

Field House Publishing

Access to resources Recommend Favorite

Neutralizing Antibodies to Interferon-β and other Immunological Treatments for Multiple Sclerosis: Prevalence and Impact on Outcomes

By Deisenhammer Florian  

CNS Drugs, Vol. 23, Iss. 5, 2009-05 ,pp. : 379-396

Adis International

Access to resources Recommend Favorite

Novel Approaches for Identification of Broadly Cross-Reactive HIV-1 Neutralizing Human Monoclonal Antibodies and Improvement of Their Potency

By  

Current Pharmaceutical Design, Vol. 13, Iss. 2, 2007-01 ,pp. : 203-212

Bentham Science Publishers

Access to resources Recommend Favorite

Evaluation of Microspheres Containing Cytokine Neutralizing Antibodies in Endotoxemia

By D'Souza Martin   Oettinger Carl   Milton Grace  

Drug Development and Industrial Pharmacy, Vol. 25, Iss. 6, 1999-05 ,pp. : 727-734

Informa Healthcare

Access to resources Recommend Favorite